Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Triazolopyrazinone derivative useful as a human PDE1 inhibitor

Triazolopyrazinone derivative useful as a human PDE1 inhibitor

US Patent 10138244 · Granted Nov 27, 2018

Estimated economic value: $565,573,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors2022
[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
[1,2,4]Triazolo[4,3-A]pyrazin-6(5H)-one derivatives2021
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019
Bicyclic heteroaryl amine compounds2019
PDE1 inhibitor2018
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2018
Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitors2018
Tricyclic sulfones as RORγ modulators2017
CGRP receptor antagonists2017
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2016
Nicotinamide compounds useful as kinase modulators2013